A 29-year-old woman with a history of recurrent ovulation induction failures presents with primary infertility for 3 years. She has regular menstrual cycles (28–30 days), normal BMI (22 kg/m²), normal FSH (6 mIU/mL), normal prolactin (18 ng/mL), and normal thyroid function. Transvaginal ultrasound shows bilateral polycystic ovaries with 12–15 follicles per ovary. She has undergone three cycles of clomiphene citrate (50–100 mg daily for 5 days) without ovulation. Which is the most appropriate next step in management?

Explanation

## Clomiphene-Resistant PCOS: Management Algorithm This patient meets criteria for **clomiphene-resistant PCOS**: - Polycystic ovaries on imaging - Regular cycles but anovulation (implied by infertility despite normal FSH/prolactin/thyroid) - Failure to ovulate after adequate clomiphene citrate dosing (50–100 mg × 3 cycles) ### Why Gonadotropins Are the Gold Standard Next Step **Key Point:** In clomiphene-resistant PCOS, exogenous gonadotropins bypass the need for endogenous FSH receptor sensitivity and directly stimulate follicular development. - **Mechanism:** Clomiphene works via estrogen receptor antagonism in the hypothalamus/pituitary, increasing endogenous FSH release. In PCOS, despite normal FSH levels, ovulation fails due to: - Abnormal FSH receptor signaling - Excessive LH:FSH ratio - Insulin resistance and hyperinsulinemia impairing follicular maturation - **Gonadotropin advantage:** Exogenous FSH or hMG directly stimulates the ovary, circumventing the pituitary-dependent mechanism. - **PCOS-specific dosing:** Start with **low-dose FSH** (75–150 IU daily) with careful ultrasound monitoring to minimize OHSS risk (PCOS patients are at high risk due to ovarian hypersensitivity). ### Clinical Pearl **High-Yield:** ASRM and ESHRE guidelines recommend gonadotropins as first-line second-line therapy for clomiphene-resistant PCOS, with low-dose protocols preferred. --- ## Why Other Options Are Incorrect **Option 0 (Increase clomiphene to 150 mg):** - Clomiphene doses >100 mg daily do NOT improve ovulation rates in resistant cases - Further dose escalation is futile; the problem is not insufficient drug but impaired ovarian receptor sensitivity - Wastes time and increases side effects (hot flushes, mood changes, endometrial thinning) **Option 2 (Proceed directly to IVF):** - IVF is not indicated as a second-line therapy for anovulation - IVF is reserved for tubal factor, male factor, or failed ovulation induction after gonadotropins - Premature escalation bypasses proven medical therapy and increases cost/morbidity **Option 3 (Add metformin, retry clomiphene):** - Metformin improves ovulation rates in insulin-resistant PCOS when added *before* first-line clomiphene - After 3 failed clomiphene cycles, adding metformin and retreating with clomiphene is unlikely to succeed - The patient's BMI is normal (22 kg/m²), suggesting lower insulin resistance; metformin benefit is less predictable - Delays definitive therapy (gonadotropins) --- ## Mnemonic: PCOS Ovulation Induction Ladder **CLOMIPHENE → GONADOTROPINS → IVF** - Clomiphene-sensitive → ovulate with clomiphene - Clomiphene-resistant → switch to gonadotropins (low-dose in PCOS) - Gonadotropin failure or tubal/male factor → IVF